²©¾ÅÓéÀÖÍø

Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical…More trials/post approval. With their subsidiaries, Cognigen Corporation and DILIsym Services, they offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, KIWIâ„¢, DILIsym®, NAFLDsym®, PKPlusâ„¢, and more) to bridge data mining, compound library screening with QSAR models, PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Simulations Plus technology is licensed to and used by regulatory agencies worldwide.